(Q42219295)

18 October 2017

title

"High-dose" calcitriol for control of renal osteodystrophy in children on CAPD. (English)

1 reference

18 October 2017

1 reference

Salusky IB

1

1 reference

18 October 2017

Fine RN

2

1 reference

18 October 2017

Kangarloo H

3

1 reference

18 October 2017

Gold R

4

1 reference

18 October 2017

Paunier L

5

1 reference

18 October 2017

Goodman WG

6

1 reference

18 October 2017

Brill JE

7

1 reference

18 October 2017

Gilli G

8

1 reference

18 October 2017

Slatopolsky E

9

1 reference

18 October 2017

Coburn JW

10

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 July 1987

1 reference

18 October 2017

1 reference

18 October 2017

volume

32

1 reference

18 October 2017

issue

1

1 reference

18 October 2017

page(s)

89-95

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1987.176

18 October 2017

exact match

0 references

cites work

Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Renal osteodystrophy in children treated with 1,25-dihydroxy-cholecalciferol [1,25-(OH)2D3]. Histologic bone studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Nutritional status of children undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Age dependence of serum enzymatic activities (alkaline phosphatase, aspartate aminotransferase, and creatine kinase) in healthy children and adolescents.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

A Review: Short Stature in Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1987.176

7 January 2021

Identifiers

DOI

10.1038/KI.1987.176

1 reference

18 October 2017

1 reference